Predictive factors associated with a pathologic complete response in a Mexican HER2+ breast cancer population.

e12630Background: The current standard of treatment for locally advanced and early HER2+ breast cancer is the use of neoadjuvant chemotherapy (NAC) in combination with trastuzumab and pertuzumab. M...